Market Share and Costs of Biologic Therapies for Inflammatory Bowel Disease in the United States

BACKGROUND: Real-world data quantifying the costs of increasing biologics use in inflammatory bowel disease (IBD) are unknown. AIM: To determine the outpatient IBD drug utilization trends, relative market share, and costs in the United States during a nine-year period. METHODS: The Truven MarketScan...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Aliment Pharmacol Ther
Главные авторы: Yu, Helen, MacIsaac, Donna, Wong, Jessie J., Sellers, Zachary M., Wren, Anava A., Bensen, Rachel, Kin, Cindy, Park, KT
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5760274/
https://ncbi.nlm.nih.gov/pubmed/29164650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14430
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы